BMT CTN 1703/1801: Ph3 Randomized of Tac/Mtx vs. PTCy in GVHD prophylaxis in RIC PBSC transplant
What is the Purpose of this Study?
Who Can Participate in this Study?
Adults that are undergoing allogeneic PBSC transplant for the treatment of acute leukemia and chronic myelogenous leukemia.
What is Involved?
If you choose to be in the study you will be asked to go through a medical screening that includes a physical, a heart test (EKG and Echo) a breathing test, and potentially a bone marrow biopsy.
If still eligible you will be asked to:
-Take the study medication as directed
-Continue treatment as you would with any transplant
Companion Study: BMT CTN 1801: Microbiome and Immune Reconstitution in Cellular Therapies and Hematopoietic Stem Cell Transplantation (Mi-Immune)